Novo Nordisk's Wegovy gets UK approval for use to lower heart risks – Reuters.com

  1. Novo Nordisk’s Wegovy gets UK approval for use to lower heart risks  Reuters.com
  2. Weight-loss drug given green light to tackle heart problems  BBC.com
  3. MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults  GOV.UK
  4. Wegovy wins…

[ad_2]

Source link

More From Author

New mental health clinic opens at NUMC

‘Super-gonorrhea’ is rare. But the STI is smart — and doctors are concerned.

Leave a Reply

Your email address will not be published. Required fields are marked *